Ingredient
Ethyl Perfluoroisobutyl Ether
Ethyl Perfluoroisobutyl Ether is flagged for pregnancy, breastfeeding, postpartum, trying to conceive, PCOS and general use. The concern behind the strongest flag is absorbed into the body and fetal development.
- Perfluorinated Ether
- Fluorinated Solvent
Verdict by profile
Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.
- Strongest verdict
- Caution Advised
- Its verdict for pregnancy, the profile this one is worst in
- Profiles flagged
- 6 of 6
- Counting avoid, high risk and medium risk
- Irritancy
- 2 of 5
- Higher means more likely to sting or redden
Ethyl Perfluoroisobutyl Ether and pregnancy
Caution Advised
- Absorbed into the body
- Fetal development
Ethyl perfluoroisobutyl ether is a fluorinated solvent belonging to the PFAS (per- and polyfluoroalkyl substances) family, used in cosmetics for its volatility and texture-enhancing properties. PFAS are often called 'forever chemicals' because they persist in the environment and accumulate in biological systems. While specific studies on this exact compound during pregnancy are lacking, PFAS chemicals as a class raise concerns. Research on other PFAS compounds has shown they can cross the placental barrier and have been associated with adverse pregnancy outcomes including reduced birth weight and developmental effects. The CDC has identified PFAS exposure as a concern for pregnant women, though most research focuses on drinking water and dietary exposure rather than cosmetics. The potential for skin absorption and the compound's persistence create theoretical concerns. The ECHA is actively evaluating PFAS restrictions in cosmetics, and several European countries are moving toward bans. While there are no specific ACOG guidelines on cosmetic PFAS, the precautionary principle suggests many pregnant women may choose to avoid PFAS-containing products when alternatives are available. Dermatologists increasingly recommend minimizing exposure to persistent chemicals during pregnancy.
Ethyl Perfluoroisobutyl Ether and breastfeeding
Caution Advised
- Passes into breast milk
- Absorbed into the body
Ethyl perfluoroisobutyl ether is a PFAS compound, and PFAS chemicals are known to be persistent and bioaccumulative. Research on other PFAS compounds has detected them in breast milk, indicating that these chemicals can transfer from mother to infant through breastfeeding. While specific data on this exact compound is limited, the chemical structure and properties of fluorinated compounds suggest they can accumulate in the body and potentially transfer to breast milk. Studies have detected various PFAS compounds in human breast milk globally, raising concerns about infant exposure to these persistent chemicals. The AAD and toxicology experts increasingly recommend that breastfeeding women minimize exposure to PFAS compounds when possible. While cosmetic use may contribute less exposure than dietary or water sources, the persistent nature of these chemicals and their detection in breast milk suggest cautious avoidance is prudent during breastfeeding.
Ethyl Perfluoroisobutyl Ether and postpartum
Caution Advised
- Absorbed into the body
Ethyl perfluoroisobutyl ether is a PFAS compound with concerns about environmental persistence and potential bioaccumulation. While specific postpartum risks beyond breastfeeding are not well-defined, the compound's persistent nature means it can accumulate in the body over time. Women not breastfeeding may choose to minimize PFAS exposure as these compounds have been associated with endocrine disruption and immune system effects in animal studies. The long-term health implications of cosmetic PFAS exposure are still being researched, and increasing regulatory attention suggests a trend toward avoidance when alternatives exist.
Ethyl Perfluoroisobutyl Ether and trying to conceive
Caution Advised
- Absorbed into the body
- Builds up in tissue
Ethyl perfluoroisobutyl ether is a PFAS compound that can persist and accumulate in the body. Research on other PFAS chemicals has suggested potential effects on reproductive health and fertility, though data on this specific compound is limited. Women trying to conceive may choose to minimize PFAS exposure in the preconception period, as these persistent chemicals can take time to clear from the body. While cosmetic exposure is likely lower than environmental sources, reducing the body burden of PFAS before pregnancy is a reasonable precautionary measure given the compounds' potential to affect fetal development.
Ethyl Perfluoroisobutyl Ether and PCOS
Caution Advised
- Endocrine disruptor
Ethyl perfluoroisobutyl ether belongs to the PFAS chemical family, which has raised concerns about potential endocrine disruption. Some PFAS compounds have been shown in research to interfere with hormonal systems, though data on this specific compound is limited. For women with PCOS, who already experience hormonal imbalances, minimizing exposure to potential endocrine disruptors is often recommended. While cosmetic use may result in lower exposure than environmental or dietary sources, the persistent and bioaccumulative nature of PFAS creates theoretical concerns about long-term hormonal effects. Many dermatologists and endocrinologists recommend that women with PCOS avoid known or suspected endocrine-disrupting chemicals when possible. Given the increasing regulatory concern about PFAS and the availability of alternative ingredients, choosing PFAS-free products may be prudent for women managing PCOS.
Ethyl Perfluoroisobutyl Ether and general use
Caution Advised
- Environmental pollutant
- Endocrine disruptor
Ethyl perfluoroisobutyl ether is a fluorinated solvent in the PFAS family, used in cosmetics for texture and volatility. PFAS chemicals are concerning because they persist in the environment indefinitely, bioaccumulate in humans and wildlife, and contaminate water supplies globally. While specific toxicity data for this compound is limited, PFAS as a class have been associated with various health concerns including endocrine disruption, immune system effects, elevated cholesterol, and potential carcinogenicity. The CDC and EPA have identified PFAS exposure as a public health concern, though most focus has been on drinking water rather than cosmetics. The ECHA is considering restrictions on PFAS in cosmetics, and several countries including Denmark and some US states are moving toward bans. Consumer advocacy groups recommend avoiding PFAS in personal care products due to environmental and health concerns. While this ingredient may function effectively in formulations, safer alternatives are widely available.
Everything else flagged for the same profiles
Related ingredients
Ingredients suggested in place of Ethyl Perfluoroisobutyl Ether, each one with its own page here.
Ingredients that raise the same concerns.
Where this came from
Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.
Assessment last pulled from the ingredient database on .
One ingredient is the easy case.
A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.
Download on theApp Store